Agonist-induced inositol phospholipid metabolism and Ca++ flux in human platelet activation.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D002118:Calcium / Q000097:blood*; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D010712:Phosphatidic Acids / Q000097:blood; D019269:Phosphatidylinositol 4,5-Diphosphate; D010716:Phosphatidylinositols / Q000097:blood*; D010972:Platelet Activating Factor / Q000502:physiology; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D011493:Protein Kinase C / Q000097:blood; D012701:Serotonin / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology
D010712:Phosphatidic Acids; D019269:Phosphatidylinositol 4,5-Diphosphate; D010716:Phosphatidylinositols; D010972:Platelet Activating Factor; D011450:Prostaglandin Endoperoxides, Synthetic; D014667:Vasopressins; D012701:Serotonin; C028429:U 44069; D000244:Adenosine Diphosphate; D011493:Protein Kinase C; D013917:Thrombin; D002118:Calcium; D004837:Epinephrine